Exabis Library
Welcome to the e-CCO Library!
P109: Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P109: Risk of cervical cancer in incident Ulcerative Colitis during the first 10 years after diagnosis: A nationwide population-based study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P109: Using baseline Peripheral blood mononuclear cell (PBMC) transcriptomics of Crohn Disease patients receiving Ustekinumab treatment as a tool to assess potential response at 1 year
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P110 Identification of the tryptophan metabolite 3-hydroxyanthranilic acid as a novel tool for the differentiation of Crohn’s disease phenotypes
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P110: Characterization of human intestinal macrophage subsets in health and inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P110: Cigarette smoke modulates the effect of dextran sulfate sodium–induced colitis on a subpopulation of T-cells in blood and colon in mice
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P110: Fibroblast activation protein is strongly expressed in intestinal fibrosis in inflammatory bowel disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P110: Inter-rater validity of a new scoring index for Crohn’s disease (Crohn's disease activity in capsule endoscopy)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P110: Risk Factors of Clinical Relapses in Pediatric Luminal Crohn’s Disease, a Retrospective Cohort Study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P110: Symptomology and most bothersome symptoms among pediatric Crohn’s disease and ulcerative colitis patients: Results from a physician and patient survey
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P110: TIGIT expression identifies circulating CD38+ effector T cells with immune regulatory properties whose frequencies at diagnosis predict disease course of paediatric IBD patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P111 Elucidation of inflammatory infiltration of myenteric plexus in IBD
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P111: Clinical validation of a blood-based prognostic biomarker in Inflammatory bowel disease; towards personalised medicine in IBD
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P111: Cross-sectional imaging is highly sensitive in detecting endoscopic post-operative recurrence in Crohn’s disease patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P111: Differences in therapies and intestinal resection rates between adult and elderly onset Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P111: Efficacy of a novel long-acting lipidated interleukin-22, alone and in combination with anti-TNF treatment, in a murine chronic DSS colitis model
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P111: Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT): A possible new target in inflammatory bowel diseases
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P111: Gut barrier markers in Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P111: The anti-inflammatory effect of a serine protease inhibitor in a chronic colitis transfer model is mediated by the suppression of Th1 cell differentiation
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P112 Body composition and resting energy expenditure in IBD patients receiving biological therapy
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM